Project Orbis: Implications for Access and Pricing in the UK

Published on January 19, 2023

Post-Brexit, the UK’s MHRA is looking to join Project Orbis, a global program to speed up patient access to innovative cancer treatments. This article looks at the implications of Project Orbis for commercialization in the UK and the key considerations for industry in considering the project as a pathway.

Continue reading on website
Other news

Amid Supply Chain Disruptions and Demand Shifts, Brands Rethink Pricing Strategies

January 19, 2023
Optimizing sales and promotions via tech will be a key goal for businesses going forward to price right and maximize margins.

Insurers must address bias in AI

January 19, 2023
Recently, a group of U.S. senators wrote a letter urging the Equal Employment Opportunity Commission to address employers' use of Artificial Intelligence (AI), machine learning, and other hiring technologies that might result in discrimination.